Modulation of dopamine tone induces frequency shifts in cortico-basal ganglia beta oscillations

Nat Commun. 2021 Dec 2;12(1):7026. doi: 10.1038/s41467-021-27375-5.

Abstract

Βeta oscillatory activity (human: 13-35 Hz; primate: 8-24 Hz) is pervasive within the cortex and basal ganglia. Studies in Parkinson's disease patients and animal models suggest that beta-power increases with dopamine depletion. However, the exact relationship between oscillatory power, frequency and dopamine tone remains unclear. We recorded neural activity in the cortex and basal ganglia of healthy non-human primates while acutely and chronically up- and down-modulating dopamine levels. We assessed changes in beta oscillations in patients with Parkinson's following acute and chronic changes in dopamine tone. Here we show beta oscillation frequency is strongly coupled with dopamine tone in both monkeys and humans. Power, coherence between single-units and local field potentials (LFP), spike-LFP phase-locking, and phase-amplitude coupling are not systematically regulated by dopamine levels. These results demonstrate that beta frequency is a key property of pathological oscillations in cortical and basal ganglia networks.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology*
  • Animals
  • Basal Ganglia / diagnostic imaging
  • Basal Ganglia / drug effects
  • Basal Ganglia / metabolism*
  • Basal Ganglia / physiopathology
  • Beta Rhythm / drug effects
  • Beta Rhythm / physiology*
  • Carbidopa / pharmacology
  • Cerebral Cortex / diagnostic imaging
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism*
  • Cerebral Cortex / physiopathology
  • Chlorocebus aethiops
  • Dopamine / metabolism
  • Dopamine / pharmacology*
  • Electrodes, Implanted
  • Eye-Tracking Technology
  • Female
  • Humans
  • Levodopa / pharmacology
  • Magnetic Resonance Imaging
  • Nerve Net / diagnostic imaging
  • Nerve Net / drug effects
  • Nerve Net / metabolism
  • Nerve Net / physiopathology
  • Organic Chemicals / pharmacology
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / metabolism*
  • Parkinson Disease / physiopathology
  • Parkinsonian Disorders / diagnostic imaging
  • Parkinsonian Disorders / metabolism*
  • Parkinsonian Disorders / physiopathology
  • Pupil / drug effects
  • Pupil / physiology
  • Stereotaxic Techniques

Substances

  • Organic Chemicals
  • dopicar
  • Levodopa
  • Carbidopa
  • Dopamine

Associated data

  • figshare/10.6084/m9.figshare.16660858
  • figshare/10.6084/m9.figshare.16660819